MicroRNA-181a promotes docetaxel resistance in prostate cancer cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-181a promotes docetaxel resistance in prostate cancer cells
Authors
Keywords
-
Journal
PROSTATE
Volume 77, Issue 9, Pages 1020-1028
Publisher
Wiley
Online
2017-05-09
DOI
10.1002/pros.23358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF1 expression
- (2016) Junya Azumi et al. CANCER SCIENCE
- MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway
- (2016) Xiaohui Zhang et al. PLoS One
- miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues
- (2016) Laura R. Saunders et al. Aging-US
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer
- (2015) Y. Zhu et al. CLINICAL CANCER RESEARCH
- Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer
- (2015) J Niu et al. ONCOGENE
- Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition
- (2015) Chengfei Liu et al. PROSTATE
- MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2)
- (2013) Xuyang Jiao et al. BREAST CANCER RESEARCH AND TREATMENT
- Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1
- (2013) M Mimeault et al. BRITISH JOURNAL OF CANCER
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD
- (2013) Yiran Chen et al. EXPERIMENTAL CELL RESEARCH
- Castration-Resistant Prostate Cancer: AUA Guideline
- (2013) Michael S. Cookson et al. JOURNAL OF UROLOGY
- Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer
- (2013) Y. Zhu et al. MOLECULAR CANCER THERAPEUTICS
- Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of twist1, YB-1, and androgen receptor
- (2013) Masaki Shiota et al. PROSTATE
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Guidelines for the management of castrate-resistant prostate cancer
- (2012) Fred Saad et al. CUAJ-Canadian Urological Association Journal
- Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
- (2012) Jordi Codony-Servat et al. PROSTATE
- Functional p53 determines docetaxel sensitivity in prostate cancer cells
- (2012) Chengfei Liu et al. PROSTATE
- miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
- (2011) Bin Xu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
- (2011) Amanda J O'Neill et al. Molecular Cancer
- Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
- (2011) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling
- (2011) Lu Gan et al. PROSTATE
- Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
- (2010) Guo-hai Shi et al. ACTA PHARMACOLOGICA SINICA
- miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras
- (2010) Ki-Hyuk Shin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis
- (2010) Wen Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis
- (2010) Wen Gao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions
- (2010) Shenglin Huang et al. NUCLEIC ACIDS RESEARCH
- The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex
- (2010) Lakshmanane Boominathan PLoS One
- Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells
- (2009) Junfang Ji et al. HEPATOLOGY
- Knockdown of microRNA-181 by lentivirus mediated siRNA expression vector decreases the arrhythmogenic effect of skeletal myoblast transplantation in rat with myocardial infarction
- (2009) Yi-Gang Li et al. MICROVASCULAR RESEARCH
- Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs
- (2009) Rajendra K Singh et al. Molecular Cancer
- An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a
- (2009) Peter J R Ebert et al. NATURE IMMUNOLOGY
- The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells
- (2008) Marina Zemskova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started